Literature DB >> 12504890

Increased beta-actin and tubulin polymerization in regrowing axons: relationship to the conditioning lesion effect.

Linda M Lund1, Victor M Machado, Irvine G McQuarrie.   

Abstract

Spinal motor neurons of Sprague-Dawley rats were examined to determine which of the neuronal isoforms of actin (beta or gamma) upregulate following axon injury. In situ hybridization studies showed greater beta-actin mRNA levels but no change in gamma-actin mRNA levels-suggesting that axon regrowth utilizes beta-actin. We radiolabeled the newly synthesized actin and tubulin that are subsequently transported in the axon to the site of an axotomizing injury. This allowed us to evaluate changes in polymerization as new cytoskeletal elements approach the injury site. Previous studies had shown that the rate of the most rapid subcomponent of actin and tubulin transport (called SCb) accelerates following axotomy (J. Jacob and I. McQuarrie, J. Neurobiol. 22: 570-583, 1991). This rate increase is associated with an increased proportion of SCb tubulin and actin in polymer (vs monomer) form (J. Jacob and I. McQuarrie, J. Neurosci, Res. 43: 412-419, 1996). However, in that study newly synthesized proteins were radiolabeled at 7 days after axotomy-which is at the peak of increased protein synthesis. This time-course did not examine actin and tubulin that were already in transit in axons when the injury occurred. This actin and tubulin would enter the regrowing axons first. Here, we have radiolabeled newly synthesized proteins 3 days prior to axotomy. For beta-tubulin, the ratio of monomer to polymer was unaffected. For actin, the equilibrium shifted strongly toward polymerization. We conclude that the acceleration of axonal outgrowth seen after the second of two serial axotomies (the "conditioning lesion effect") is related to the ability of actin that is already in transit to polymerize in response to the first axotomy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12504890     DOI: 10.1006/exnr.2002.8034

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Electrical stimulation accelerates and enhances expression of regeneration-associated genes in regenerating rat femoral motoneurons.

Authors:  Abdulhakeem A Al-Majed; Siu Lin Tam; Tessa Gordon
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

2.  Quantification of gene expression after painful nerve injury: validation of optimal reference genes.

Authors:  Madhavi Latha Yadav Bangaru; Frank Park; Andy Hudmon; J Bruce McCallum; Quinn H Hogan
Journal:  J Mol Neurosci       Date:  2011-08-24       Impact factor: 3.444

3.  Gene expression profile in rat dorsal root ganglion following sciatic nerve injury and systemic neurotrophin-3 administration.

Authors:  Lu-Ting Kuo; Shao-Yu Tsai; Michael J Groves; Shu F An; Francesco Scaravilli
Journal:  J Mol Neurosci       Date:  2011-03       Impact factor: 3.444

4.  Intrinsic response of thoracic propriospinal neurons to axotomy.

Authors:  Justin R Siebert; Frank A Middelton; Dennis J Stelzner
Journal:  BMC Neurosci       Date:  2010-06-04       Impact factor: 3.288

Review 5.  CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure.

Authors:  Michael T Fitch; Jerry Silver
Journal:  Exp Neurol       Date:  2007-05-31       Impact factor: 5.330

6.  Serum response factor mediated gene activity in physiological and pathological processes of neuronal motility.

Authors:  Bernd Knöll
Journal:  Front Mol Neurosci       Date:  2011-12-06       Impact factor: 5.639

7.  Activity-dependent degeneration of axotomized neuromuscular synapses in Wld S mice.

Authors:  R Brown; A Hynes-Allen; A J Swan; K N Dissanayake; T H Gillingwater; R R Ribchester
Journal:  Neuroscience       Date:  2015-01-21       Impact factor: 3.590

8.  Effect of lesion proximity on the regenerative response of long descending propriospinal neurons after spinal transection injury.

Authors:  Kristen Swieck; Amanda Conta-Steencken; Frank A Middleton; Justin R Siebert; Donna J Osterhout; Dennis J Stelzner
Journal:  BMC Neurosci       Date:  2019-03-18       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.